Wipperman, Matthew F

Affiliation

member of

Clinical and Translational Science Center

Publications

Sort by

Co-Author Network

selected publications

Dupilumab normalizes the eosinophilic esophagitis disease transcriptome. The Journal of allergy and clinical immunology. 2026 Academic Article GET IT
Validity of a Wearable Digital Insole for Assessing Gait ON and OFF in Parkinson's Disease. Annals of clinical and translational neurology. 2026 Academic Article GET IT
Identification of alkaline phosphatase as a putative biomarker of anti-NGF treatment-associated arthropathies: Machine learning-assisted analyses of clinical trial data. Osteoarthritis and cartilage open. 2025 Academic Article GET IT
The IL-33 and IL-4Rα blocking antibodies itepekimab and dupilumab modulate both distinct and common inflammatory mediators in asthma. Science translational medicine. 2025 Academic Article GET IT
Times cited: 7
SARS-CoV-2 vaccine failure rates and predictors of immune response in a diverse immunocompromised patient population. Vaccine. 2025 Academic Article GET IT
Times cited: 2
Reliable monitoring of respiratory function with home spirometry in people living with amyotrophic lateral sclerosis. Frontiers in neurology. 2025 Academic Article GET IT
Times cited: 2
Monoclonal antibodies against the spike protein alter the endogenous humoral response to SARS-CoV-2 vaccination and infection. Science translational medicine. 2024 Academic Article GET IT
Times cited: 5
Potential immunomodulatory effects of CAS+IMD monoclonal antibody cocktail in hospitalized patients with COVID-19. EBioMedicine. 2024 Academic Article GET IT
Times cited: 1
Digital measurement of mobility in pulmonary arterial hypertension: A structured review of an emerging area. Digital health. 2024 Information Resource GET IT
Times cited: 1
Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age. The New England journal of medicine. 2024 Academic Article GET IT
Times cited: 85
Digital wearable insole-based identification of knee arthropathies and gait signatures using machine learning. eLife. 2024 Academic Article GET IT
Times cited: 1
Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy. Allergy. 2024 Academic Article GET IT
Times cited: 25
Defining a Unique Gene Expression Profile in Mature and Developing Keloids. JID innovations : skin science from molecules to population health. 2023 Academic Article GET IT
Times cited: 6
Dupilumab in Adults and Adolescents with Eosinophilic Esophagitis. The New England journal of medicine. 2022 Academic Article GET IT
Times cited: 397
Association of complement pathways with COVID-19 severity and outcomes. Microbes and infection. 2022 Academic Article GET IT
Times cited: 14
Elevated serum IgA following vaccination against SARS-CoV-2 in a cohort of high-risk first responders. Scientific reports. 2022 Academic Article GET IT
Times cited: 16
Influence of the early-life gut microbiota on the immune responses to an inhaled allergen. Mucosal immunology. 2022 Academic Article GET IT
Times cited: 35
A pilot study of the Earable device to measure facial muscle and eye movement tasks among healthy volunteers. PLOS digital health. 2022 Academic Article GET IT
Times cited: 3
Exploring the value of Mycobacterium tuberculosis modified lipoprotein as a potential biomarker for TB detection in children. BMC infectious diseases. 2022 Academic Article GET IT
Times cited: 1
Anti-SARS-CoV-2 IgA Identifies Asymptomatic Infection in First Responders. The Journal of infectious diseases. 2022 Academic Article GET IT
Times cited: 8
Baseline Severe Acute Respiratory Syndrome Viral Load Is Associated With Coronavirus Disease 2019 Severity and Clinical Outcomes: Post Hoc Analyses of a Phase 2/3 Trial. The Journal of infectious diseases. 2021 Academic Article GET IT
Times cited: 21
The Activin/FLRG Pathway Associates with Poor COVID-19 Outcomes in Hospitalized Patients. Molecular and cellular biology. 2021 Academic Article GET IT
Times cited: 7
Transcriptomic Biomarkers for Tuberculosis: Validation of NPC2 as a Single mRNA Biomarker to Diagnose TB, Predict Disease Progression, and Monitor Treatment Response. Cells. 2021 Academic Article GET IT
Times cited: 7
Developing a Novel Measurement of Sleep in Rheumatoid Arthritis: Study Proposal for Approach and Considerations. Digital biomarkers. 2021 Academic Article GET IT
Times cited: 7
Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis. Nature communications. 2021 Academic Article GET IT
Times cited: 47
Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis. Nature communications. 2021 Academic Article GET IT
Times cited: 47
An Antibiotic-Impacted Microbiota Compromises the Development of Colonic Regulatory T Cells and Predisposes to Dysregulated Immune Responses. mBio. 2021 Academic Article GET IT
Times cited: 55
IpdE1-IpdE2 Is a Heterotetrameric Acyl Coenzyme A Dehydrogenase That Is Widely Distributed in Steroid-Degrading Bacteria. Biochemistry. 2020 Academic Article GET IT
Times cited: 13
Mammalian Target of Rapamycin: A Metabolic Rheostat for Regulating Adipose Tissue Function and Cardiovascular Health. The American journal of pathology. 2019 Information Resource GET IT
Times cited: 36
Mucosal-associated invariant and γδ T cell subsets respond to initial Mycobacterium tuberculosis infection. JCI insight. 2018 Academic Article GET IT
Times cited: 70
The Microbiome and Tuberculosis: Early Evidence for Cross Talk. mBio. 2018 Information Resource GET IT
Times cited: 79
Mycobacterial Mutagenesis and Drug Resistance Are Controlled by Phosphorylation- and Cardiolipin-Mediated Inhibition of the RecA Coprotease. Molecular cell. 2018 Academic Article GET IT
Times cited: 21
Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed. Scientific reports. 2017 Academic Article GET IT
Times cited: 173
Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy. Microbiome. 2017 Academic Article GET IT
Times cited: 138
Unraveling Cholesterol Catabolism in Mycobacterium tuberculosis: ChsE4-ChsE5 α₂β₂ Acyl-CoA Dehydrogenase Initiates β-Oxidation of 3-Oxo-cholest-4-en-26-oyl CoA. ACS infectious diseases. 2015 Academic Article GET IT
Times cited: 55
Pathogen roid rage: cholesterol utilization by Mycobacterium tuberculosis. Critical reviews in biochemistry and molecular biology. 2014 Information Resource GET IT
Times cited: 131
Experimental evidence of a cyclopropylcarbinyl conjugative electronic effect. Organic & biomolecular chemistry. 2013 Academic Article GET IT
Times cited: 3
Shrinking the FadE proteome of Mycobacterium tuberculosis: insights into cholesterol metabolism through identification of an α2β2 heterotetrameric acyl coenzyme A dehydrogenase family. Journal of bacteriology. 2013 Academic Article GET IT
Times cited: 61
Thermal isomerizations of cis,anti,cis-tricyclo[7.4.0.0(2,8)]tridec-10-ene. The Journal of organic chemistry. 2012 Academic Article GET IT
Times cited: 4

more ...

less ...

Background

education and training

M.Sc., Cornell University 2017
Ph.D., State University of New York at Stony Brook 2015
B.A., Franklin and Marshall College 2011

Contact

full name

Matthew F Wipperman

Identity

eRA Commons ID

MFWIPPERMAN

VIVO Weill Cornell Medical College

Matthew F Wipperman Assistant Professor of Pathology and Laboratory Medicine in Medicine (Courtesy)

Affiliation

member of

Publications

selected publications

Background

education and training

Contact

full name

Identity

eRA Commons ID